MedTrace Logo

Immunophenotyping of Acute b Cell Lymphoblstic Leukemia

NCT04084327 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-09-10

No results posted yet for this study

Summary

To study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute iand its correlation with disease outcome

Conditions

Interventions

OTHER

stastical analysis

1-Clinical examination data-Complete Blood Count (CBC).Bone Marrow Aspiration (BMA)-Bone Marrow Biopsy (BMB). (if available)-Immunophenotyping results (IPT).Cytogenetic results

Sponsors & Collaborators

  • South Egypt Cancer Institute

    lead OTHER

Eligibility

Min Age
12 Months
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-12-01
Completion
2022-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04084327 on ClinicalTrials.gov